Valuation: Beijing Airdoc Technology Co., Ltd.

Market Cap 980M 1.13B 144M 126M 116M 108M 205M 13.76B 208M 1.39B 542M 6.76B 542M 530M 23.42B P/E 2026 *
-26x
P/E 2027 * -480x
Enterprise Value 980M 1.13B 144M 126M 116M 108M 205M 13.76B 208M 1.39B 542M 6.76B 542M 530M 23.42B EV / Sales 2026 *
3.89x
EV / Sales 2027 * -
Free-Float
18.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.45%
1 week-0.36%
Current month-0.36%
1 month-7.07%
3 months-0.45%
6 months-9.29%
Current year-3.41%
1 week 10.43
Extreme 10.43
11.25
1 month 10.2
Extreme 10.2
12
Current year 9.81
Extreme 9.81
13.77
1 year 9.81
Extreme 9.81
16
3 years 7.88
Extreme 7.88
18.38
5 years 7.88
Extreme 7.88
74.95
10 years 7.88
Extreme 7.88
74.95
Manager TitleAgeSince
Chief Executive Officer 43 2015-09-08
General Counsel - 2021-02-28
Corporate Secretary - 2022-01-18
Director TitleAgeSince
Chairman 43 2015-09-08
Director/Board Member 63 2020-12-24
Director/Board Member 53 2020-12-24
Date Insider Type Main position Quantity % Market Cap.
05-28Other

Chief Executive Officer

-165,400 0.1597%
01-19Other

Chief Executive Officer

418,500 0.4041%
25-09-23Other

Chief Executive Officer

35,000 0.0338%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%-0.36%-15.85%+1.85% 144M
-0.38%+8.96%-32.46%-1.71% 31.19B
-1.42%+3.59%-32.01%+234.83% 15.5B
+0.37%+7.21%-16.21%+63.21% 5.86B
-3.06%-22.21% - - 2.34B
-2.81%+0.06% - - 2.17B
+5.14%+10.56%+51.61%-35.60% 2.06B
-0.49%-17.12%-30.54% - 1.11B
+2.39%+5.55%-32.40%+306.65% 817M
-6.13%-5.56%+512.00%+992.86% 747M
Average -0.68%+0.56%+50.52%+223.15% 6.19B
Weighted average by Cap. -0.61%+6.63%-20.50%+86.58%

Financials

2026 *2027 *
Net sales 252M 291M 37.09M 32.48M 29.92M 27.77M 52.74M 3.54B 53.45M 358M 139M 1.74B 139M 136M 6.02B -
Net income -39M -45.02M -5.74M -5.03M -4.63M -4.3M -8.16M -548M -8.27M -55.43M -21.57M -269M -21.56M -21.08M -932M -
Net Debt - -
Logo Beijing Airdoc Technology Co., Ltd.
Beijing Airdoc Technology Co Ltd is a China-based company primarily engaged in providing artificial intelligence (AI)-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company’s main products include Myopia Prevention and Control AI (PBM-AI), Retinal Detection AI (Retina AI) and Stress Resilience Monitoring AI (Neuro-AI). The Company offers health risk assessment solutions with the ability to detect risk indicators, including risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease and anemia. The Company conducts its business in the domestic and overseas markets.
Employees
181
Date Price Change Volume
26-07-07 HK$11.04 -0.45% 68,500
26-07-06 HK$11.09 +1.19% 47,100
26-07-03 HK$10.96 0.00% 51,800
26-07-02 HK$10.96 -1.08% 0
26-06-30 HK$11.08 -0.63% 64,500
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.608CNY
Average target price
11.22CNY
Spread / Average Target
+16.77%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2251 Stock